4/A
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-034314
Zawel Leigh sold 28,118 shares at an average $26.77 ($752,850)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-09 | Sale : show line 1 in the form | −19,504 | $26.52 | $517,246 | 130,256 | D |
| 2021-08-09 | Sale : show line 2 in the form | −1,700 | $27.11 | $46,087 | 128,556 | D |
| 2021-08-10 | Sale : show line 3 in the form | −1,906 | $26.50 | $50,509 | 126,650 | D |
| 2021-08-10 | Sale : show line 4 in the form | −3,191 | $27.34 | $87,242 | 123,459 | D |
| 2021-08-10 | Sale : show line 5 in the form | −1,817 | $28.49 | $51,766 | 121,642 | D |
| Open-market sales · 28,118 sh · avg $26.77 · $752,850 | ||||||
Loading xslF345X03/doc4a.xml…